| Target Price | $28.56 |
| Price | $20.37 |
| Potential |
40.21%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target Omada Health Inc 2027 .
The average Omada Health Inc target price is $28.56.
This is
40.21%
register free of charge
$36.75
80.41%
register free of charge
$22.22
9.08%
register free of charge
|
|
| A rating was issued by 18 analysts: 15 Analysts recommend Omada Health Inc to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Omada Health Inc stock has an average upside potential 2027 of
40.21%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 260.21 | 345.27 |
| 53.24% | 32.69% | |
| EBITDA Margin | -4.43% | 7.64% |
| 82.51% | 272.42% | |
| Net Margin | -4.91% | 1.70% |
| 82.31% | 134.61% |
14 Analysts have issued a sales forecast Omada Health Inc 2026 . The average Omada Health Inc sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Omada Health Inc EBITDA forecast 2026. The average Omada Health Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Omada Health Inc Analysts have issued a net profit forecast 2026. The average Omada Health Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.35 | 0.10 |
| 58.82% | 128.57% | |
| P/E | 210.22 | |
| EV/Sales | 2.97 |
13 Analysts have issued a Omada Health Inc forecast for earnings per share. The average Omada Health Inc EPS is
This results in the following potential growth metrics and future valuations:
Omada Health Inc...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Freedom Capital Markets |
Locked
➜
Locked
|
Locked | Sep 14 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Sep 11 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Sep 11 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Sep 11 2026 |
| Citizens |
Locked
➜
Locked
|
Locked | Aug 14 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Aug 14 2026 |
| Baird |
Locked
➜
Locked
|
Locked | Aug 12 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Freedom Capital Markets:
Locked
➜
Locked
|
Sep 14 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Sep 11 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Sep 11 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 11 2026 |
|
Locked
Citizens:
Locked
➜
Locked
|
Aug 14 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 14 2026 |
|
Locked
Baird:
Locked
➜
Locked
|
Aug 12 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


